...
首页> 外文期刊>Infection and immunity >Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice.
【24h】

Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice.

机译:纯化的铜绿假单胞菌外膜蛋白F(孔蛋白)制剂在小鼠中作为保护性疫苗的用途。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The outer membrane protein F (porin) from the PAO1 strain of Pseudomonas aeruginosa was purified by two different methods. One procedure involved separation by column chromatography of proteins extracted from isolated outer membranes, whereas the other involved extraction from gels after slab polyacrylamide gel electrophoresis of proteins extracted from cell envelopes. Both procedures yielded protein F preparations which successfully immunized mice from subsequent challenge with the PAO1 strain. The protein F preparations contained small quantities of lipopolysaccharide (LPS). This level of LPS contamination protected immunized mice from challenge with the homologous LPS serotype strain. However, immunization of mice with protein F preparations from the PAO1 strain also afforded protection against challenge with two different LPS serotype strains. This protective ability was lost when the protein F preparation was treated with papain before use as a vaccine. These observations support the conclusion that protein F has protective ability, which is not due to LPS contamination, when given as a vaccine. After immunization with the protein F preparation, mice showed an increase in antibody titer to the purified protein F preparation by enzyme-linked immunosorbent assay. Mice were protected passively by administration of rabbit antisera raised to the protein F preparation. These results indicate that the protein F preparation elicits a specific humoral antibody response in immunized animals. Our results suggest that purified protein F has potential as an effective vaccine for P. aeruginosa.
机译:铜绿假单胞菌的PAO1菌株的外膜蛋白F(孔蛋白)通过两种不同的方法纯化。一种方法涉及通过柱色谱分离从分离出的外膜中提取的蛋白质,而另一种方法涉及在平板聚丙烯酰胺凝胶电泳后对从细胞膜提取的蛋白质进行凝胶提取。两种方法均产生了蛋白F制剂,该制剂成功免疫了小鼠,使其免受随后用PAO1株攻击。蛋白F制剂含有少量脂多糖(LPS)。此水平的LPS污染可保护免疫小鼠免受LPS血清型同源株的攻击。但是,用来自PAO1株的蛋白F制剂免疫小鼠也提供了针对两种不同LPS血清型株的攻击的保护。当蛋白F制剂在用作疫苗之前用木瓜蛋白酶处理时,失去了这种保护能力。这些观察结果支持以下结论:蛋白F作为疫苗给予时具有保护能力,这不是LPS污染引起的。用蛋白F制剂免疫后,小鼠通过酶联免疫吸附法显示出与纯化的蛋白F制剂相比的抗体效价增加。通过给予提高至蛋白F制剂的兔抗血清,被动保护小鼠。这些结果表明蛋白F制剂在免疫动物中引起特异性的体液抗体应答。我们的结果表明,纯化的蛋白F具有作为铜绿假单胞菌有效疫苗的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号